# Promaxo

Promaxo is the FDA-cleared point-of-care MRI platform for prostate interventions.

Promaxo is the FDA-cleared point-of-care MRI platform for prostate interventions.

Canonical: https://uniquebase.ai/companies/promaxo
Stable identifier: UB-C11451
Snapshot captured: 2026-11-01T00:40:31.077Z
English updated: 2026-11-01T02:03:53.090Z

## Funding

Listed 1 record.
Latest: $1.43M (Series C), 2026-10-22.

- 2026-10-22 · $1.43M · Series C · https://www.globenewswire.com/news-release/2026/10/22/3386416/0/en/promaxo-announces-closing-of-series-c-financing-and-100m-credit-facility.html
  > On 2026-10-22, according to GlobeNewswire, Promaxo completes funding round C. (translated source brief)

## Valuation

Listed 1 record.

- 2026-10-22 · amount unavailable · Series C · https://www.globenewswire.com/news-release/2026/10/22/3386416/0/en/promaxo-announces-closing-of-series-c-financing-and-100m-credit-facility.html
  > On 2026-10-22, according to GlobeNewswire, Promaxo completes funding round C. (translated source brief)

## Revenue

No revenue records are listed yet.


## Team

No published team profiles are linked yet.

## Products

No published products profiles are linked yet.

## Investors

No published investors profiles are linked yet.

## Sources

- No source links are available for this profile.